BlackRock Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $92K | Sell |
7,387
-32
| -0.4% | -$399 | ﹤0.01% | 2988 |
|
|
2016
Q3 | $103K | Buy |
7,419
+951
| +15% | +$13.2K | ﹤0.01% | 2937 |
|
|
2016
Q2 | $64K | Buy |
6,468
+459
| +8% | +$4.54K | ﹤0.01% | 3099 |
|
|
2016
Q1 | $102K | Hold |
6,009
| – | – | ﹤0.01% | 2855 |
|
|
2015
Q4 | $134K | Sell |
6,009
-2,537
| -30% | -$56.6K | ﹤0.01% | 2745 |
|
|
2015
Q3 | $202K | Sell |
8,546
-3,158
| -27% | -$74.6K | ﹤0.01% | 2687 |
|
|
2015
Q2 | $957K | Buy |
11,704
+7,102
| +154% | +$581K | ﹤0.01% | 1658 |
|
|
2015
Q1 | $426K | Buy |
4,602
+1,366
| +42% | +$126K | ﹤0.01% | 2160 |
|
|
2014
Q4 | $131K | Buy |
3,236
+598
| +23% | +$24.2K | ﹤0.01% | 2858 |
|
|
2014
Q3 | $65K | Sell |
2,638
-601
| -19% | -$14.8K | ﹤0.01% | 3164 |
|
|
2014
Q2 | $51K | Sell |
3,239
-853
| -21% | -$13.4K | ﹤0.01% | 3220 |
|
|
2014
Q1 | $62K | Sell |
4,092
-987
| -19% | -$15K | ﹤0.01% | 3173 |
|
|
2013
Q4 | $70K | Sell |
5,079
-113,667
| -96% | -$1.57M | ﹤0.01% | 3143 |
|
|
2013
Q3 | $2.24M | Buy |
+118,746
| New | +$2.24M | ﹤0.01% | 1126 |
|